Home » Topics » BioWorld Science

BioWorld Science
RSS

Phoenix PharmaLabs receives support to study PPL-103 for cocaine addiction

Sep. 6, 2018

DSMB recommends continuation of phase IIb study of OPT-302 in wet AMD

Sep. 6, 2018

AIC-649 stimulates the immune system of patients with chronic HBV in phase I trial

Sep. 6, 2018

Adocia reports phase I data on BioChaperone Pramlintide Insulin in type 1 diabetes

Sep. 6, 2018

OncoArendi Therapeutics presents new AMCase and CHIT1 dual inhibitors for lung diseases

Sep. 6, 2018

Enanta Pharmaceuticals divulges new NR1H4 agonists

Sep. 6, 2018

Argenx initiates phase III trial of efgartigimod in generalized myasthenia gravis

Sep. 6, 2018

Daewoong Pharmaceutical patents EPRS inhibitors

Sep. 6, 2018

Summit Therapeutics names lead clinical candidate for gonorrhea

Sep. 6, 2018

Phase I/II interim data on QR-110 in LCA10 support progression to phase II/III

Sep. 6, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...